Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_1
1
20%
Ph not_applicable
1
20%
Ph phase_2
3
60%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
3(60.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (20.0%)
Phase 23 (60.0%)
N/A1 (20.0%)

Trials by Status

completed360%
recruiting120%
not_yet_recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
completedphase_2

Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study

NCT07000734
not_yet_recruitingphase_2

Palmitic Acid and Human Microvascular Function

NCT06683534
completedphase_2

Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia

NCT03476330
recruitingnot_applicable

Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.

NCT07466420
completedphase_1

Quercetin in Children With Fanconi Anemia; a Pilot Study

NCT01720147

Clinical Trials (5)

Showing 5 of 5 trials
NCT07000734Phase 2

Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study

Completed
NCT06683534Phase 2

Palmitic Acid and Human Microvascular Function

Not Yet Recruiting
NCT03476330Phase 2

Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia

Completed
NCT07466420Not Applicable

Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.

Recruiting
NCT01720147Phase 1

Quercetin in Children With Fanconi Anemia; a Pilot Study

Completed

All 5 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
5